Does Dr. MOHAMMADBAGHER ZIARI have financial conflicts of interest?

Dr. MOHAMMADBAGHER ZIARI (MD) has received a total of $1,980,063 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,980,063 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MOHAMMADBAGHER ZIARI?

According to CMS Open Payments data, Dr. MOHAMMADBAGHER ZIARI received funding from ASTRAZENECA PHARMACEUTICALS ($669,637), REGENERON HEALTHCARE SOLUTIONS ($330,024), and KARYOPHARM THERAPEUTICS ($271,332).

Does Dr. MOHAMMADBAGHER ZIARI receive research grants or speaking fees?

Dr. MOHAMMADBAGHER ZIARI has received $1,980,063 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MOHAMMADBAGHER ZIARI

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: CORONA, CA 92879

NPI Number: 1962601047

LIFETIME INDUSTRY VALUE

$1,980,063

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ZIARI is a verified Internal Medicine, Hematology & Oncology practitioner based in CORONA, CA.

Between 2021 and 2025, Dr. ZIARI had an overall industry promotional and research financial footprint of $1,980,063 as recorded in the federal CMS Open Payments database.

$1,980,063 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ZIARI's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $669,637 (representing 33.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$669,637

33.8%

REGENERON HEALTHCARE SOLUTIONS

Rank 2

$330,024

16.7%

KARYOPHARM THERAPEUTICS

Rank 3

$271,332

13.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.